-
1
المؤلفون: Koji Kawai, Satoshi Nagamori, Katherine M Bell-McGuinn, Cristiano Ferrario, Wen Pin Su, Isabel Syndikus, Aude Flechon, Georgios Gakis, Timothy Dudley Clay, Leticia Vazquez Cortés, Ronald de Wit, Florence Joly, Bozena Sikora-Kupis, Sergio Bracarda, Astra M. Liepa, Annemie Rutten, Daniel P. Petrylak, Su Peng Yeh, Annamaria Zimmermann, Sameera R. Wijayawardana, Mutsushi Kawakita, Siobhan Ng, Thean Hsiang Tan, Chikara Ohyama, Yu Jung Kim, Yuriy Golovko, Dimitrios Mavroudis, Jian Ri Li, Reinoud J. B. Blaisse, Mustafa Erman, Francesca Russo, Catherine Becht, Anghel Adrian Udrea, Robert Huddart, Syed A. Hussain, Fransiscus L.G. Erdkamp, Satoshi Fukasawa, Francesco Massari, Motohide Uemura, Boris Alekseev, Irfan Cicin, Se Hoon Park, Marcello Tucci, Lajos Géczi, Maureen J.B. Aarts, Yu Li Su, Fumimasa Fukuta, Hyo Jin Lee, Wolfgang Schultze-Seemann, Alexandra Drakaki, Hakan Harputluoglu, Xavier Garcia del Muro, Santhanam Sundar, Avivit Peer, Herlinde Dumez, William E. Lawler, Juan Ignacio Delgado Mignorance, Naveed Sarwar, Jeanny B. Aragon-Ching, Benjamin T. Herms, Fredrik Laestadius, Nobuaki Matsubara, Ivan Sinielnikov, Cora N. Sternberg, Hiroyuki Nishiyama, Piotr Tomczak, Brigitte Laguerre, Rebecca R. Hozak, Vasilis Karavasilis, Christina A. Schwentner, Hiroyuki Tsunemori, Masayoshi Nagata, Igor Bondarenko, Andrea Necchi, Yen Chuan Ou, Scott T. Tagawa, Constance Thibault, Richard A. Walgren, Akira Yokomizo, Evan Y. Yu, Alejo Rodriguez-Vida, Sufia Safina, Ulka N. Vaishampayan, János Révész, Aristotelis Bamias, Jae-Lyun Lee, Chien Liang Lin, Thomas W. Flaig, Roman Fomkin, Petr Alexandrovich Karlov, Joanna Wojcik-Tomaszewska, Junichi Inokuchi, Wataru Obara, Haralambos Kalofonos, John D. Hainsworth, Marc-Oliver Grimm, Thomas Eugene Lowe, Pablo Gajate Borau, Simon J. Crabb, Lisa Sengeloev, Junji Yonese, Simon Chowdhury, Elizabeth Jane Hovey, Daniel Castellano, Peter Istvan Acs, Chia-Chi Lin, Claudia Lorena Urzua Flores, Jean-Pascal Machiels, Kim N. Chi, Takahiro Osawa, Nobuo Shinohara, Daniel Kejzman, Günter Niegisch, David Sarid, Yuksel Urun, Yun Gyoo Lee, Oday Hamid, Alina Amalia Herzal, Michael Schenker, Eli Rosenbaum, Enrique Grande, Raya Leibowitz-Amit, Naoto Miyajima, Michiel S. van der Heijden, Shinichi Yamashita, Susanna Yee Shan Cheng, Kazuo Nishimura, Sun Young Rha, Thomas Powles, Hasan Şenol Coşkun, Jens Bedke, Ivor J. Percent, Christos Papandreou, James K. Schwarz, Masafumi Oyama, Giorgio V. Scagliotti, Chong-Xian Pan, Yoshihiko Tomita, Giampaolo Tortora, Stéphane Culine, Suet Lai Shirley Wong, Andrey Semenov, Jennifer L. Cultrera, Niels Viggo Jensen, Michael Stöckle, Katsuyoshi Hashine
المساهمون: Medical Oncology, UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Unité d'oncologie médicale, UCL - (SLuc) Centre du cancer, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Petrylak, Dp, de Wit, R, Chi, Kn, Drakaki, A, Sternberg, Cn, Nishiyama, H, Castellano, D, Hussain, Sa, Flechon, A, Bamias, A, Yu, Ey, van der Heijden, M, Matsubara, N, Alekseev, B, Necchi, A, Geczi, L, Ou, Yc, Coskun, H, Su, Wp, Bedke, J, Gakis, G, Percent, Ij, Lee, Jl, Tucci, M, Semenov, A, Laestadius, F, Peer, A, Tortora, G, Safina, S, del Muro, Xg, Rodriguez-Vida, A, Cicin, I, Harputluoglu, H, Tagawa, St, Vaishampayan, U, Aragon-Ching, Jb, Hamid, O, Liepa, Am, Wijayawardana, S, Russo, F, Walgren, Ra, Zimmermann, Ah, Hozak, Rr, Bell-McGuinn, Km, Powles, T, Graduate School
المصدر: Lancet Oncology, 21(1), 105-120. Lancet Publishing Group
The Lancet. Oncology, Vol. 21, no.1, p. 105-120 (2020)
Lancet oncology, 21(1), 105-120. Elsevier Science
lancet oncology, 21(1), 105-120. Lancet Publishing Groupمصطلحات موضوعية: Male, 0301 basic medicine, MULTICENTER, Docetaxel, Gastroenterology, ANGIOGENESIS, VINFLUNINE, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Neoplasm Metastasis, education.field_of_study, CHEMOTHERAPY, Middle Aged, OPEN-LABEL, Prognosis, Survival Rate, Oncology, 030220 oncology & carcinogenesis, Female, medicine.drug, EXPRESSION, Urologic Neoplasms, medicine.medical_specialty, BEVACIZUMAB, Population, BLADDER-CANCER, Neutropenia, Antibodies, Monoclonal, Humanized, Placebo, Ramucirumab, 03 medical and health sciences, Double-Blind Method, Internal medicine, medicine, Humans, Neoplasm Invasiveness, education, Survival rate, Aged, Platinum, Salvage Therapy, Carcinoma, Transitional Cell, business.industry, medicine.disease, ATEZOLIZUMAB, 030104 developmental biology, ENDOTHELIAL GROWTH-FACTOR, business, Febrile neutropenia, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf61e6c114a1ba3c5764d0e77ad9425aTest
https://doi.org/10.1016/s1470-2045Test(19)30668-0 -
2
المؤلفون: Enrique Grande, A. Loehr, Petros Grivas, Dale L. Nepert, Yohann Loriot, Sumati Gupta, Daleen Thomas, Nicholas J. Vogelzang, Min Yuen Teo, Nabil Adra, Alejo Rodriguez-Vida, Rachel L. Dusek, Simon Chowdhury, S. Srinivas, Yousef Zakharia, Andrew Simmons, Andrea Necchi, Ajjai Alva, Susan Feyerabend, Kenton Wride, Rafael Morales-Barrera, Debra H. Josephs
المساهمون: University of Washington [Seattle], Fred Hutchinson Cancer Research Center [Seattle] (FHCRC), Biomarqueurs prédictifs et nouvelles stratégies moléculaires en thérapeutique anticancéreuse (U981), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Passeig Vall d'Hebron [Barcelona, Spain], Memorial Sloane Kettering Cancer Center [New York], University of Iowa [Iowa City], Studienpraxis Urologie [Nürtingen, Germany], Comprehensive Cancer Centers [Las Vegas, NV, USA], MD Anderson Cancer Center [Madrid, Spain], Indiana State University, Department of Internal Medicine and Computational Medicine and Bioinformatics [Ann Arbor, MI, USA], University of Michigan [Ann Arbor], University of Michigan System-University of Michigan System, Human Tumor Immunobiology Unit [Fondazione IRCCS Istituto Nazionale dei Tumori, Milan], Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan], IMIM-Hospital del Mar, Generalitat de Catalunya, Huntsman Cancer Institute [Salt Lake City], University of Utah, Guy's and St Thomas NHS Foundation Trust [London], Stanford University School of Medicine [CA, USA], Clovis Oncology, Inc. [Boulder, CO, USA], Malbec, Odile, Institut Català de la Salut, [Grivas P] Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA 98109, USA. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. Seattle Cancer Care Alliance, Seattle, WA 98109, USA. [Loriot Y] Department of Medicine, Gustave Roussy Cancer Campus, INSERM U981, Université Paris-Saclay, 94800 Villejuif, France. [Morales-Barrera R] Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Teo MY] Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. [Zakharia Y] Division of Hematology, Oncology, and Blood and Marrow Transplant, University of Iowa and Holden Comprehensive Cancer Center, Iowa City, IA 52242, USA. [Feyerabend S] Studienpraxis Urologie, 72622 Nürtingen, Germany, Vall d'Hebron Barcelona Hospital Campus, Grivas, P., Loriot, Y., Morales-Barrera, R., Teo, M. Y., Zakharia, Y., Feyerabend, S., Vogelzang, N. J., Grande, E., Adra, N., Alva, A., Necchi, A., Rodriguez-Vida, A., Gupta, S., Josephs, D. H., Srinivas, S., Wride, K., Thomas, D., Simmons, A., Loehr, A., Dusek, R. L., Nepert, D., Chowdhury, S.
المصدر: BMC Cancer
BMC Cancer, BioMed Central, 2021, 21 (1), pp.593. ⟨10.1186/s12885-021-08085-z⟩
BMC Cancer, 2021, 21 (1), pp.593. ⟨10.1186/s12885-021-08085-z⟩
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
Scientiaمصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Indoles, DNA Repair, [SDV]Life Sciences [q-bio], Administration, Oral, Loss of Heterozygosity, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Prostate cancer, chemistry.chemical_compound, 0302 clinical medicine, Clinical endpoint, Inhibidors enzimàtics - Ús terapèutic - Eficàcia, RC254-282, BRCA1 Protein, Bladder cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Progression-Free Survival, 3. Good health, [SDV] Life Sciences [q-bio], 030220 oncology & carcinogenesis, Bufeta - Càncer - Tractament, Other subheadings::Other subheadings::/administration & dosage [Other subheadings], Female, Urothelial carcinoma, medicine.symptom, Research Article, medicine.medical_specialty, Metastatic Urothelial Carcinoma, Anemia, Nausea, Urinary Bladder, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Poly(ADP-ribose) Polymerase Inhibitors, 03 medical and health sciences, Internal medicine, Genetics, medicine, Humans, Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Poly(ADP-ribose) Polymerase Inhibitors [CHEMICALS AND DRUGS], Adverse effect, Rucaparib, Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Urologic Neoplasms::Urinary Bladder Neoplasms [DISEASES], Response Evaluation Criteria in Solid Tumors, Aged, BRCA2 Protein, Genomic biomarkers, Carcinoma, Transitional Cell, Otros calificadores::Otros calificadores::/administración & dosificación [Otros calificadores], neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias urológicas::neoplasias de la vejiga [ENFERMEDADES], business.industry, acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::inhibidores enzimáticos::inhibidores de poli(ADP-ribosa) polimerasas [COMPUESTOS QUÍMICOS Y DROGAS], medicine.disease, PARP inhibitor, 030104 developmental biology, Urinary Bladder Neoplasms, chemistry, business, Follow-Up Studies
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fd23d13c81759eb9e25d93f435c085cTest
https://doi.org/10.1186/s12885-021-08085-zTest -
3
المؤلفون: Karen Urtishak, Gerhardt Attard, Michael Gormley, Alexander W. Wyatt, Shibu Thomas, Yashoda Rajpurohit, Brendan Rooney, Angela Lopez-Gitlitz, Mark Li, David Olmos, Simon Chowdhury, Eric J. Small, Matthew R. Smith, Margaret K. Yu, Stéphane Oudard, Deborah Ricci, Felix Y. Feng
المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research. 27(16)
مصطلحات موضوعية: Oncology, Male, Cancer Research, medicine.medical_specialty, medicine.drug_class, Disease, Risk Assessment, Androgen deprivation therapy, Prostate cancer, chemistry.chemical_compound, Internal medicine, Biomarkers, Tumor, Medicine, Humans, In patient, Neoplasm Metastasis, Aged, Aged, 80 and over, business.industry, Apalutamide, Androgen Antagonists, Middle Aged, medicine.disease, Androgen, Androgen receptor, Survival Rate, Prostatic Neoplasms, Castration-Resistant, chemistry, Thiohydantoins, Disease Progression, Biomarker (medicine), Drug Therapy, Combination, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a9b8e275b9ef43e367307ef790b1c2eTest
https://pubmed.ncbi.nlm.nih.gov/34112710Test -
4
المؤلفون: Archana Fernando, Hannah Warren, Kay Thomas, Conal Austin, Simon Chowdhury, Tim O'Brien
المصدر: BJU International. 124:462-468
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Adolescent, Urology, medicine.medical_treatment, Vena Cava, Inferior, Kidney, Thrombophilia, computer.software_genre, Nephrectomy, Inferior vena cava, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Interquartile range, Renal cell carcinoma, Humans, Medicine, 030212 general & internal medicine, Aged, Retrospective Studies, Aged, 80 and over, Database, business.industry, Cancer, Retrospective cohort study, Middle Aged, Prognosis, medicine.disease, Kidney Neoplasms, Surgery, medicine.vein, 030220 oncology & carcinogenesis, Cohort, Female, business, computer
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::994ddbf3976b47bf657cd5e9a8724837Test
https://doi.org/10.1111/bju.14755Test -
5
المؤلفون: Matthew R. Smith, Brendan Rooney, Eric J. Small, Sharon Anne McCarthy, Boris Hadaschik, Margaret K. Yu, Yang Liu, David Olmos, Elai Davicioni, Shibu Thomas, Michael Gormley, Deborah Ricci, Sabine Brookman-May, Simon Chowdhury, Fred Saad, Felix Y. Feng
مصطلحات موضوعية: Oncology, Male, Cancer Research, medicine.medical_specialty, Medizin, Androgen deprivation therapy, Cohort Studies, 03 medical and health sciences, Basal (phylogenetics), chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Internal medicine, Androgen Receptor Antagonists, Medicine, Humans, 030212 general & internal medicine, Aged, Aged, 80 and over, business.industry, Hazard ratio, Apalutamide, Androgen Antagonists, Middle Aged, medicine.disease, Primary tumor, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, chemistry, Thiohydantoins, 030220 oncology & carcinogenesis, Biomarker (medicine), business, Cohort study
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e5180992960a385de69e7da3af1e4e2Test
https://www.ncbi.nlm.nih.gov/pubmed/34081076Test -
6
المؤلفون: Peter De Porre, David Olmos, Simon Chowdhury, Hiroji Uemura, Susan Li, Brendan Rooney, Andressa Smith, Paul N. Mainwaring, Ji Youl Lee, Ke Zhang, Angela Lopez-Gitlitz, Matthew R. Smith, Julie N. Graff, Fred Saad, Eric J. Small, Boris Hadaschik, Sabine Brookman-May, Stéphane Oudard
مصطلحات موضوعية: Male, medicine.medical_specialty, Urology, 030232 urology & nephrology, Medizin, Placebo, Androgen deprivation therapy, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Statistical significance, Apalutamide, medicine, Humans, Overall survival, Time to cytotoxic chemotherapy, Aged, Cross-Over Studies, business.industry, Nonmetastatic castration-resistant prostate cancer, Hazard ratio, Middle Aged, medicine.disease, Confidence interval, Discontinuation, Survival Rate, Prostatic Neoplasms, Castration-Resistant, chemistry, Thiohydantoins, 030220 oncology & carcinogenesis, business, Progressive disease, Subsequent therapy
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10a09b9be709255bffc9e05e55db5954Test
https://www.ncbi.nlm.nih.gov/pubmed/32907777Test -
7
المؤلفون: Thomas Powles, Michiel S van der Heijden, Daniel Castellano, Matthew D Galsky, Yohann Loriot, Daniel P Petrylak, Osamu Ogawa, Se Hoon Park, Jae-Lyun Lee, Ugo De Giorgi, Martin Bögemann, Aristotelis Bamias, Bernhard J Eigl, Howard Gurney, Som D Mukherjee, Yves Fradet, Iwona Skoneczna, Marinos Tsiatas, Andrey Novikov, Cristina Suárez, André P Fay, Ignacio Duran, Andrea Necchi, Sophie Wildsmith, Philip He, Natasha Angra, Ashok K Gupta, Wendy Levin, Joaquim Bellmunt, Michiel S. van der Heijden, Jae Lyun Lee, Bernhard J. Eigl, Som D. Mukherjee, Cristina Suarez, Hans Westgeest, Aude Flechon, Yen-Chuan Ou, Inkeun Park, Vsevolod Matveev, Begoña Pérez-Valderrama, Susanna Cheng, Stephen Frank, Urbano Anido, Alketa Hamzaj, Margitta Retz, Srikala Sridhar, Giorgio Vittorio Scagliotti, Jens Voortman, Boris Alekseev, Anna Alyasova, Boris Komyakov, Herlinde Dumez, Michel Pavic, Go Kimura, Atsushi Mizokami, Susanne Osanto, Jose Angel Arranz, Djura Piersma, Sang Joon Shin, Oleg Karyakin, Ignacio Delgado, Jose Luis Gonzalez, See-Tong Pang, Anna Tran, Oleg Lipatov, Wen-Pin Su, Thomas Flaig, Ajjai Alva, Hwa Park Kyong, Evgeny Kopyltsov, Elena Almagro, Monserrat Domenech, Yen-Hwa Chang, Brieuc Sautois, Andre Ravaux, Gerasimos Aravantinos, Vasileios Georgoulias, Sasja Mulder, Yu Jung Kim, Fabio Kater, Christine Chevreau, Scott Tagawa, Pawel Zalewski, Florence Joly, Gencay Hatiboglu, Luca Gianni, Franco Morelli, Rosa Tambaro, Yasuhiro Hashimoto, Alexander Nosov, Albert Font, Alejo M. Rodriguez-Vida, Robert Jones, Naveen Vasudev, Sandhya Srinivas, Jingsong Zhang, Thierry Gil, Daygen Finch, Marc-Oliver Grimm, Yu-Li Su, Simon Chowdhury, Christopher Hocking, Eugen Plas, Scott North, Niels Viggo Jensen, Christine Theodore, Florian Imkamp, Avivit Peer, Takashi Kobayashi, Hideki Sakai, Naoto Sassa, Kazuhiro Yoshimura, Maureen Aarts, Ana Ferreira Castro, Marlen Topuzov, Juan Francisco Rodriguez, Federico Jose Vazquez, Yu-Chieh Tsai, Simon Crabb, Syed Hussain, Johanna Bendell, Marine Gross-Goupil, Gravis Gwenaelle, Raanan Berger, Galina Statsenko, Linda Evans, Alexandra Drakaki, Bradley Somer, Ian Davis, James Lynam, Giuliano Borges, Aldo Dettino, André P. Fay, Graziella Martins, Luis Eduardo Zucca, Mads Agerbaek, Haralambos Kalofonos, Eli Rosenbaum, Hideki Enokida, Hiroaki Kikukawa, Kazuo Nishimura, Satoshi Tamada, Motohide Uemura, Yamil Lopez, Jourik Gietema, Marcin Slojewski, Isabel Fernandes, Alexey Smolin, Danish Mazhar, Arash Rezazadeh Kalebasty, Bradley Carthon, Wolfgang Loidl, Fabio Franke, Gustavo Girotto, Nimira Alimohamed, Robyn Macfarlane, Helle Pappot, Guenter Niegisch, Dimitrios Mavroudis, Avishay Sella, Camillo Porta, Shin Ebara, Motonobu Nakamura, Wataru Obara, Norihiko Okuno, Nobuo Shinohara, Mikio Sugimoto, Akitaka Suzuki, Noriaki Tokuda, Hiroji Uemura, Akito Yamaguchi, Francisco Ramirez, Pawel Rozanowski, Pawel Wiechno, Bhumsuk Keam, Nikolay Kislov, Denis Plaksin, Irfan Cicin, Satish Kumar, Matthew D. Galsky, Daniel P. Petrylak, Joseph Rosales, Ulka Vaishampayan, Stephane Culine, Christos Papandreou, Taketoshi Nara, Mustafa Erman, Laurence Kreiger, Juliana Janoski, Diogo Rosa, Mariana Siqueira, Christina Canil, Lisa Sengelov, Jean-Marc Tourani, Gaku Arai, Katsuyoshi Hashine, Mutsushi Kawakita, Noboru Nakaigawa, Hayahito Nomi, Hiroaki Shiina, Hiroyoshi Suzuki, Junji Yonese, Roberto Kuri, Eleazar Macedo, Samuel Rivera, Alberto Villalobos Prieto, Anna Polakiewicz-Gilowska, Renata Zaucha, Fabio Lopes, Roman Ponomarev, Mark Pomerantz, Shahrokh Shariat, Cynthia Luk, Krzysztof Lesniewski-Kmak
المساهمون: Graduate School, CCA - Cancer Treatment and quality of life, Internal medicine, Medical oncology, Powles, T., van der Heijden, M. S., Castellano, D., Galsky, M. D., Loriot, Y., Petrylak, D. P., Ogawa, O., Park, S. H., Lee, J. -L., De Giorgi, U., Bogemann, M., Bamias, A., Eigl, B. J., Gurney, H., Mukherjee, S. D., Fradet, Y., Skoneczna, I., Tsiatas, M., Novikov, A., Suarez, C., Fay, A. P., Duran, I., Necchi, A., Wildsmith, S., He, P., Angra, N., Gupta, A. K., Levin, W., Bellmunt, J., Lee, J. L., Westgeest, H., Flechon, A., Ou, Y. -C., Park, I., Matveev, V., Perez-Valderrama, B., Cheng, S., Frank, S., Anido, U., Hamzaj, A., Retz, M., Sridhar, S., Scagliotti, G. V., Voortman, J., Alekseev, B., Alyasova, A., Komyakov, B., Dumez, H., Pavic, M., Kimura, G., Mizokami, A., Osanto, S., Arranz, J. A., Piersma, D., Shin, S. J., Karyakin, O., Delgado, I., Gonzalez, J. L., Pang, S. -T., Tran, A., Lipatov, O., Su, W. -P., Flaig, T., Alva, A., Park Kyong, H., Kopyltsov, E., Almagro, E., Domenech, M., Chang, Y. -H., Sautois, B., Ravaux, A., Aravantinos, G., Georgoulias, V., Mulder, S., Kim, Y. J., Kater, F., Chevreau, C., Tagawa, S., Zalewski, P., Joly, F., Hatiboglu, G., Gianni, L., Morelli, F., Tambaro, R., Hashimoto, Y., Nosov, A., Font, A., Rodriguez-Vida, A. M., Jones, R., Vasudev, N., Srinivas, S., Zhang, J., Gil, T., Finch, D., Grimm, M. -O., Su, Y. -L., Chowdhury, S., Hocking, C., Plas, E., North, S., Jensen, N. V., Theodore, C., Imkamp, F., Peer, A., Kobayashi, T., Sakai, H., Sassa, N., Yoshimura, K., Aarts, M., Ferreira Castro, A., Topuzov, M., Rodriguez, J. F., Vazquez, F. J., Tsai, Y. -C., Crabb, S., Hussain, S., Bendell, J., Gross-Goupil, M., Gwenaelle, G., Berger, R., Statsenko, G., Evans, L., Drakaki, A., Somer, B., Davis, I., Lynam, J., Borges, G., Dettino, A., Martins, G., Zucca, L. E., Agerbaek, M., Kalofonos, H., Rosenbaum, E., Enokida, H., Kikukawa, H., Nishimura, K., Tamada, S., Uemura, M., Lopez, Y., Gietema, J., Slojewski, M., Fernandes, I., Smolin, A., Mazhar, D., Kalebasty, A. R., Carthon, B., Loidl, W., Franke, F., Girotto, G., Alimohamed, N., Macfarlane, R., Pappot, H., Niegisch, G., Mavroudis, D., Sella, A., Porta, C., Ebara, S., Nakamura, M., Obara, W., Okuno, N., Shinohara, N., Sugimoto, M., Suzuki, A., Tokuda, N., Uemura, H., Yamaguchi, A., Ramirez, F., Rozanowski, P., Wiechno, P., Keam, B., Kislov, N., Plaksin, D., Cicin, I., Kumar, S., Rosales, J., Vaishampayan, U., Culine, S., Papandreou, C., Nara, T., Erman, M., Kreiger, L., Janoski, J., Rosa, D., Siqueira, M., Canil, C., Sengelov, L., Tourani, J. -M., Arai, G., Hashine, K., Kawakita, M., Nakaigawa, N., Nomi, H., Shiina, H., Suzuki, H., Yonese, J., Kuri, R., Macedo, E., Rivera, S., Villalobos Prieto, A., Polakiewicz-Gilowska, A., Zaucha, R., Lopes, F., Ponomarev, R., Pomerantz, M., Shariat, S., Luk, C., Lesniewski-Kmak, K., Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE)
المصدر: lancet oncology, 21(12), 1574-1588. Lancet Publishing Group
Lancet Oncology, 21(12), 1574-1588. Lancet Publishing Group
DANUBE study investigators & Voortman, J 2020, ' Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE) : a randomised, open-label, multicentre, phase 3 trial ', Lancet Oncology, vol. 21, no. 12, pp. 1574-1588 . https://doi.org/10.1016/S1470-2045Test(20)30541-6
The Lancet Oncology, 21(12), 1574-1588. ELSEVIER SCIENCE INCمصطلحات موضوعية: 0301 basic medicine, Male, medicine.medical_specialty, Urologic Neoplasms, Durvalumab, Time Factors, medicine.medical_treatment, Population, Neutropenia, Antibodies, Monoclonal, Humanized, Gastroenterology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Antineoplastic Agents, Immunological, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Medicine, Humans, education, Immune Checkpoint Inhibitors, Aged, Chemotherapy, education.field_of_study, business.industry, Hazard ratio, Carcinoma, Antibodies, Monoclonal, Middle Aged, medicine.disease, Gemcitabine, Carboplatin, 030104 developmental biology, Treatment Outcome, Oncology, chemistry, 030220 oncology & carcinogenesis, Female, Urothelium, business, Tremelimumab, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d1a55ae19ca8e730510c641cbd9a05aTest
https://pubmed.ncbi.nlm.nih.gov/33387509Test -
8
المؤلفون: Joris Diels, Jan Sermon, Dominic Pilon, Stéphane Oudard, Martin Ladouceur, Hiroji Uemura, Ajay S. Behl, Boris Hadaschik, Jinan Liu, Suzy Van Sanden, L. Dearden, Steven Joniau, Simon Chowdhury
المصدر: Advances in Therapy
مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Non-metastatic castration-resistant prostate cancer, NETWORK METAANALYSIS, Population, Medizin, Research & Experimental Medicine, ADT, Disease-Free Survival, Androgen deprivation therapy, Prostate cancer, chemistry.chemical_compound, Internal medicine, Nitriles, Phenylthiohydantoin, Androgen Receptor Antagonists, medicine, Apalutamide, Enzalutamide, Humans, Pharmacology (medical), Pharmacology & Pharmacy, education, Proportional Hazards Models, Original Research, education.field_of_study, Science & Technology, business.industry, Proportional hazards model, Hazard ratio, Bayes Theorem, General Medicine, Middle Aged, medicine.disease, Confidence interval, M0CRPC, Prostatic Neoplasms, Castration-Resistant, Thiohydantoins, chemistry, Medicine, Research & Experimental, Benzamides, SURVIVAL, business, Life Sciences & Biomedicine
وصف الملف: Print-Electronic
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e08e47107b8c90d31d1e67bdeec4d779Test
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85076552283Test -
9
المؤلفون: Pablo Maroto, Vsevolod Matveev, Florence Lefresne, M Lukac, Thomas Paiss, Ewa Kalinka, Robert Wapenaar, Alison Birtle, Dominique Spaeth, Gero Kramer, Simon Chowdhury, Susan Feyerabend, Luis Costa, Anders Bjartell, Francisco Gomez-Veiga, Nicolaas Lumen
المساهمون: Repositório da Universidade de Lisboa
المصدر: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
TARGETED ONCOLOGY
Targeted Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Population, PLUS PREDNISONE, THERAPY, 03 medical and health sciences, Prostate cancer, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, medicine, Medicine and Health Sciences, Enzalutamide, Humans, Pharmacology (medical), Original Research Article, Prospective Studies, Registries, Neoplasm Metastasis, Prospective cohort study, education, Survival rate, Aged, Aged, 80 and over, DOCETAXEL, education.field_of_study, business.industry, Abiraterone acetate, MEN, Middle Aged, medicine.disease, Clinical trial, Survival Rate, Prostatic Neoplasms, Castration-Resistant, 030104 developmental biology, Treatment Outcome, Docetaxel, chemistry, 030220 oncology & carcinogenesis, TRIAL, business, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c093077331cb43e0753a76f9060299a4Test
https://ddd.uab.cat/record/227807Test -
10
المؤلفون: Jingsong Zhang, Simon Paul Watkins, Charles J. Ryan, Nicholas J. Vogelzang, David Campbell, Simon Chowdhury, Darrin Despain, Cora N. Sternberg, Andrea Loehr, Richard Martin Bambury, Gedske Daugaard, Josep M. Piulats, Wassim Abida, Karim Fizazi, Alan H. Bryce, Brieuc Sautois, Jeremy Shapiro, Andrew Simmons, Laurence Eliot Miles Krieger, Axel S. Merseburger, Eric Voog, Tony Golsorkhi, Melanie Dowson, Celestia S. Higano, Ray McDermott, Akash Patnaik, Axel Heidenreich
المصدر: Abida, W, Patnaik, A, Campbell, D, Shapiro, J, Bryce, A H, McDermott, R, Sautois, B, Vogelzang, N J, Bambury, R M, Voog, E, Zhang, J, Piulats, J M, Ryan, C J, Merseburger, A S, Daugaard, G, Heidenreich, A, Fizazi, K, Higano, C S, Krieger, L E, Sternberg, C N, Watkins, S P, Despain, D, Simmons, A D, Loehr, A, Dowson, M, Golsorkhi, T, Chowdhury, S & TRITON2 investigators 2020, ' Rucaparib in Men with Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration ', Journal of Clinical Oncology, vol. 38, no. 32, pp. 3763-3772 . https://doi.org/10.1200/JCO.20.01035Test
Journal of Clinical Oncology
J Clin Oncolمصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, 2019-20 coronavirus outbreak, Indoles, endocrine system diseases, Castration resistant, Poly(ADP-ribose) Polymerase Inhibitors, Genitourinary Cancer, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Germline mutation, Clinical Trials, Phase II as Topic, RAPID COMMUNICATIONS, Medicine, Humans, Progression-free survival, Neoplasm Metastasis, Rucaparib, Polymerase, Germ-Line Mutation, Aged, Aged, 80 and over, BRCA2 Protein, biology, business.industry, BRCA1 Protein, Editorials, Middle Aged, medicine.disease, Progression-Free Survival, Prostatic Neoplasms, Castration-Resistant, 030104 developmental biology, Oncology, chemistry, Gene Alteration, 030220 oncology & carcinogenesis, biology.protein, Cancer research, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::271c7c2ada87d9db135e66207c386092Test
https://curis.ku.dk/ws/files/256065464/Rucaparib_in_Men_with_Metastatic_Castration_Resistant_Prostate_Cancer_Harboring_a_BRCA1_or_BRCA2_Gene_Alteration.pdfTest